RNA is hot, mergers are not: Summing up a health summit

JPMorgan Chase & Co.’s annual healthcare conference in San Francisco, which will wrap up on Thursday, has long been considered the industry’s flagship event. Executives flock to outline priorities for the year ahead, or set plans in motion behind closed doors. It’s a stage on which to announce deals or a setting for clinching them.

This post was originally published on this site